Media Tip Sheet: Work-From-Home Era Ends for Millions of Americans
Some 72.5% of business establishments said their employees teleworked rarely or not at all last year, according to a Labor Department report released this week.
View the latest updates and university statements.
Media Tip Sheet: Work-From-Home Era Ends for Millions of Americans
Some 72.5% of business establishments said their employees teleworked rarely or not at all last year, according to a Labor Department report released this week.
A new combination drug treatment showed promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to new study.
Media Tip Sheet: Fentanyl to Blame in Many Overdose Deaths
Teen overdose deaths have gone up exponentially in the last few years, a trend that many experts blame on the synthetic opioid called fentanyl.
George Washington University Experts Available to Comment on School Shooting in Nashville
According to the Gun Violence Archive, it is the 130th mass shooting in the United States in 2023 and the third to take place at a school.
Media Tip Sheet: Mitigating Air Travel Disruptions Ahead of Expected Busy Summer Travel Season
The FAA is expecting another summer travel season marred by flight delays and disruptions for East Coast airports.
Retired U.S. Supreme Court Justice Stephen Breyer, and his brother, the Honorable Charles R. Breyer, Senior District Judge, will join GW in a conversation on their pre-law school years. Alan B....
A new study suggests that E. coli from meat products may be responsible for hundreds of thousands of urinary tract infections in the U.S. each year.
Media Tip Sheet: Spring Travel Rebounding Strongly for 2023
As the spring break season gets underway in the U.S., experts say it’ll turn out to be a very busy couple of months for travel activities, both domestically and internationally.
Media Tip Sheet: GW Expert Available to Discuss Overhaul of U.S. Organ Transplant System
The Biden administration announced it will issue plans to overhaul the U.S. organ transplant system in order to shorten wait times for patients.
Largest Study to Date of Lebrikizumab Supports Its Use for Treatment of Atopic Dermatitis
Two phase 3 trials suggest that a 16 week treatment with a drug called lebrikizumab was effective in adults and adolescents with moderate to severe dermatitis, according to a paper published in the...